Search results

Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.

Researchers developing new materials and devices that can withstand the harsh radiation environment in space are using the unique ANSTO’s capability to simulate the effects of high-energy ion irradiation on the properties and performance of these materials and devices.

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.

Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.

New research published a team from the Imperial College London, University of Glasgow and ANSTO suggests that rock coasts, which make up over half the world’s coastlines, could retreat more rapidly in the future due to accelerating sea level rise.

Congress marks watershed moment for nuclear medicine and ANSTO

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.

The Nobel Prizes for Physics, Chemistry and Medicine have been announced.